The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states

Endocrine Reviews

Volumn 19, Issue 5, 1998, Pages 647-672

  Newell Price, John ^a   Trainer, Peter ^a   Besser, Michael ^a   Grossman, Ashley ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DESMOPRESSIN; DEXAMETHASONE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOCORTICOID; HEXARELIN; HYDROCORTISONE; METYRAPONE; POTASSIUM; VASOPRESSIN;

BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL FEATURE; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; CUSHINGOID SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ECTOPIC CORTICOTROPIN PRODUCTION; FEEDBACK SYSTEM; HORMONE DEPENDENCE; HORMONE INHIBITION; HUMAN; HYDROCORTISONE URINE LEVEL; IMMUNORADIOMETRIC ASSAY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW;

ACTH SYNDROME, ECTOPIC; ADRENOCORTICOTROPIC HORMONE; ANTI-INFLAMMATORY AGENTS; CIRCADIAN RHYTHM; CORTICOTROPIN-RELEASING HORMONE; CUSHING SYNDROME; DEAMINO ARGININE VASOPRESSIN; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GROWTH SUBSTANCES; HUMANS; HYDROCORTISONE; MAGNETIC RESONANCE IMAGING; MALE; METYRAPONE; OLIGOPEPTIDES; PETROSAL SINUS SAMPLING; RENAL AGENTS; TOMOGRAPHY, X-RAY COMPUTED; VASOPRESSINS;

EID: 0031697764     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.19.5.647     Document Type: Review

References (286)

1. Cushing HW 1912 The Pituitary Body and Its Disorders. JB Lippincott, Philadelphia
2. Cushing HW 1932 The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50:137-95
3. Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, Gross DJ 1996 Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf) 44:717-722
4. Trainer PJ, Grossman A 1991 The diagnosis and differential diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 34:317-330
5. Aron DC, Findling JW, Tyrrell JB 1987 Cushing's disease. Endocrinol Metab Clin North Am 16:705-730
6. Orth DN 1995 Cushing's syndrome. N Engl J Med 332:791-803
7. Findling JW, Tyrrell JB 1986 Occult ectopic secretion of corticotropin. Arch Intern Med 146:929-933
8. Delisle L, Boyer MJ, Warr D, Killinger D, Payne D, Yeoh JL, Feld R 1993 Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications. Arch Intern Med 153:746-752
9. Wajchenberg BL, Mendonca BB, Liberman B, Pereira MA, Carneiro PC, Wakamatsu A, Kirschner MA 1994 Ectopic adrenocorticotropic hormone syndrome. Endocr Rev 15:752-787
10. Upton GV, Amatruda Jr TT 1971 Evidence for the presence of tumor peptides with corticotropin-releasing-factor-like activity in the ectopic ACTH syndrome. N Engl J Med 285:419-424
11. Carey RM, Varma SK, Drake Jr CR, Thorner MO, Kovacs K, Rivier J, Vale W 1984 Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study. N Engl J Med 311:13-20
12. Muller OA, von Werder K 1992 Ectopic production of ACTH and corticotropin-releasing hormone (CRH). J Steroid Biochem Mol Biol 43:403-408
13. Samuels MH, Loriaux DL 1994 Cushing's syndrome and the nodular adrenal gland. Endocrinol Metab Clin North Am 23:555-569
14. Lacroix A, Bolte E, Tremblay J, Dupre J, Poitras P, Fournier H, Garon J, Garrel D, Bayard F, Taillefer R, Flanagan RJ, Hamet P 1992 Gastric inhibitory polypeptide-dependent cortisol hypersecretion-a new cause of Cushing's syndrome. N Engl J Med 327: 974-980
15. de Herder WW, Hofland LJ, Usdin TB, de Jong FH, Uitterlinden P, van Koetsveld P, Mezey E, Bonner TI, Bonjer HJ, Lamberts SW 1996 Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. J Clin Endocrinol Metab 81:3168-3172
16. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P 1997 Propanolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 337:1429-1434
17. Mauras N, Blizzard RM 1986 The McCune-Albright syndrome. Acta Endocrinol (Copenh) [Suppl] 279:207-217
18. Rees LH, Besser GM, Jeffcoate WJ, Goldie DJ, Marks V 1977 Alcohol-induced pseudo-Cushing's syndrome. Lancet 1:726-728
19. Groote Veldman R, Meinders AE 1996 On the mechanism of alcohol-induced pseudo-Cushing's syndrome. Endocr Rev 17:262-268
20. Jeffcoate W 1993 Alcohol-induced pseudo-Cushing's syndrome. Lancet 341:676-677
21. Kapcala LP 1987 Alcohol-induced pseudo-Cushing's syndrome mimicking Cushing's disease in a patient with an adrenal mass. Am J Med 82:849-856
22. Lamberts SW, Klijn JG, de Jong FH, Birkenhager JC 1979 Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing disease. JAMA 242:1640-1643
23. Kelly WF, Checkley SA, Bender DA 1980 Cushing's syndrome, tryptophan and depression. Br J Psychiatry 136:125-132
24. Gold PW, Chrousos GP 1985 Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiency. Psychoneuroendocrinology 10:401-419
25. Stokes PE 1995 The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. Eur Neuropsychopharmacol 5[Suppl]:77-82
26. Gold PW, Licinio J, Wong ML, Chrousos GP 1995 Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann NY Acad Sci 771:716-729
27. Koelz A, Girard J 1976 Cushing's syndrome or obesity. Bilateral adrenal hyperplasia in a boy 10 years of age. Eur J Pediatr 121: 237-246
28. Kreze A, Veleminsky J, Spirova E 1985 Low-dose dexamethasone suppression of urinary free cortisol in the differential diagnosis between Cushing's syndrome and obesity. Klin Wochenschr 63: 188-189
29. Abou Samra AB, Dechaud H, Estour B, Chalendar D, Fevre-Montange M, Pugeat M, Tourniaire J 1985 Beta-lipotropin and cortisol responses to an intravenous infusion dexamethasone suppression test in Cushing's syndrome and obesity. J Clin Endocrinol Metab 61:116-119
30. Grossman A, Howlett TA, Kopelman PG 1987 The use of CRF-41 in the differential diagnosis of Cushing's syndrome and obesity. Horm Metab Res [Suppl] 16:62-64
31. Kopelman PG 1994 Hormones and obesity. Baillieres Clin Endocrinol Metab 8:549-575
32. Peeke PM, Chrousos GP 1995 Hypercortisolism and obesity. Ann NY Acad Sci 771:665-676
33. Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C, Thalassinos N 1998 The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clin Endocrinol (Oxf) 48:627-634
34. Newell-Price J, Grossman A 1996 Adrenal incidentaloma: subclinical Cushing's syndrome. Postgrad Med J 72:207-210
35. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B 1995 Incidentally discovered adrenal masses. Endocr Rev 16:460-484
36. Ross EJ, Marshall-Jones P, Friedman M 1966 Cushing's syndrome: diagnostic criteria. Q J Med 35:149-192
37. Ross EJ, Linch DC 1982 Cushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 2:646-649
38. Yanovski JA, Cutler Jr GB 1994 Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin North Am 23:487-509
39. Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler Jr GB, Nieman LK, Chrousos GP 1994 Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 331:629-636
40. Weber A, Trainer PJ, Grossman AB, Afshar F, Medbak S, Perry LA, Plowman PN, Rees LH, Besser GM, Savage MO 1995 Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome. Clin Endocrinol (Oxf) 43:19-28
41. Bickler SW, McMahon TJ, Campbell JR, Mandel S, Piatt JH, Harrison MW 1994 Preoperative diagnostic evaluation of children with Cushing's syndrome. J Pediatr Surg 29:671-676
42. Leinung MC, Zimmerman D 1994 Cushing's disease in children. Endocrinol Metab Clin North Am 23:629-639
43. Plotz C, Knowlton A, Ragan C 1952 The natural history of Cushing's syndrome. Am J Med 13:597-614
44. Sprague RG, Randall RV, Salassa RM, Scholz DA, Priestly JT, Walters W, Bulbulian AH 1956 Cushing's syndrome: a progressive and often fatal disease. A review of 100 cases seen between July 1945 and July 1954. Arch Intern Med 98:389-398
45. Soffer L, Iannaccone A, Gabrilove J 1961 Cushing's syndrome: a study of fifty patients. Arch Intern Med 300:215-219
46. Urbanic RC, George JM 1981 Cushing's disease-18 years' experience. Medicine (Baltimore) 60:14-24
47. Atkinson AB, Kennedy AL, Carson DJ, Hadden DR, Weaver JA, Sheridan B 1985 Five cases of cyclical Cushing's syndrome. Br Med J 291:1453-1457
48. Bailey RE 1971 Periodic hormonogenesis - a new phenomenon. Periodicity in function of a hormone-producing tumor in man. J Clin Endocrinol Metab 32:317-327
49. Popovic V, Micic D, Nesovic M, Howlett T, Doniach I, Kendereski A, Djordjevic P, Manojlovic D, Micic J, Besser M 1990 Cushing's disease cycling over ten years. Exp Clin Endocrinol 96:143-148
50. Meador CK, Liddle GW, Island DP, Nicholson WE, Lucas CP, Nuckton JG, Leutscher JA 1962 Cause of Cushing's syndrome in patients with tumors arising from 'non-endocrine' tissue. J Clin Endocrinol Metab 22:693-703
51. Crapo L 1979 Cushing's syndrome: a review of diagnostic tests. Metabolism 28:955-977
52. Orth DN 1994 The Cushing syndrome: quest for the Holy Grail. Ann Intern Med 121:377-378
53. Contreras LN, Hane S, Tyrrell JB 1986 Urinary cortisol in the assessment of pituitary-adrenal function: utility of 24-hour and spot determinations. J Clin Endocrinol Metab 62:965-969
54. Mengden T, Hubmann P, Muller J, Greminger P, Vetter W 1992 Urinary free cortisol vs. 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome. Clin Invest 70:545-548
55. Nieman LK, Cutler Jr GB, The sensitivity of the urine free cortisol measurement as a screening test for Cushing's syndrome. Program of the 72nd Annual Meeeting of The Endocrine Society, Atlanta GA, 1990 (Abstract P-822)
56. Carroll BJ, Curtis GC, Davies BM, Mendels J, Sugerman AA 1976 Urinary free cortisol excretion in depression. Psychol Med 6:43-50
57. Cizza G, Nieman LK, Doppman JL, Passaro MD, Czerwiec FS, Chrousos GP, Cutler Jr GB 1996 Factitious Cushing syndrome. J Clin Endocrinol Metab 81:3573-3577
58. Yanovski JA, Cutler Jr GB, Chrousos GP, Nieman LK 1993 Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA 269:2232-2238
59. Lin CL, Wu TJ, Machacek DA, Jiang NS, Kao PC 1997 Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 82:151-155
60. Liddle GW 1960 Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab:1539-1560
61. Nugent CA, Nichols T, Tyler FH 1965 Diagnosis of Cushing' syndrome-single dose dexamethasone. Arch Intern Med 116:172-176
62. Montwill J, Igoe D, McKenna TJ 1994 The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome. Steroids 59:296-298
63. Cronin C, Igoe D, DuHy MJ, Cunningham SK, McKenna TJ 1990 The overnight dexamethasone test is a worthwhile screening procedure. Clin Endocrinol (Oxf) 33:27-33
64. Blethen SL, Chasalow FI 1989 Overnight dexamethasone suppression test: normal responses and the diagnosis of Cushing's syndrome. Steroids 54:185-193
65. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B 1997 Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 34:222-229
66. Hankin ME, Theile HM, Steinbeck AW 1977 An evaluation of laboratory tests for the detection and differential diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 6:185-196
67. Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR 1984 Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing's syndrome. Br Med J 289:1188-1191
68. Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M 1995 A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 43:545-550
69. Yanovski JA, Cutler Jr GB, Chrousos GP, Nieman LK 1998 The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology. J Clin Endocrinol Metab 83:348-352
70. Meikle AW 1982 Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone. Clin Endocrinol (Oxf) 16:401-408
71. Kapcala LP, Hamilton SM, Meikle AW 1984 Cushing's disease with 'normal suppression' due to decreased dexamethasone clearance. Arch Intern Med 144:636-637
72. Atkinson AB, McAteer EJ, Hadden DR, Kennedy L, Sheridan B, Traub AI 1989 A weight-related intravenous dexamethasone suppression test distinguishes obese controls from patients with Cushing's syndrome. Acta Endocrinol (Copenh) 120:753-759
73. Jubiz W, Meikle AW, Levinson RA, Mizutani S, West CD, Tyler FH 1970 Effect of diphenylhydantoin on the metabolism of dexamethasone. N Engl J Med 283:11-14
74. Putignano P, Kaltsas MA, Satta MA, Grossman AB 1998 The effects of anti-convulsant drugs on adrenal function. Horm Metab Res 30:389-387
75. Tiller JW, Maguire KP, Schweitzer I, Biddle N, Campbell DG, Outch K, Davies BM 1988 The dexamethasone suppression test: a study in a normal population. Psychoneuroendocrinology 13:377-384
76. Doe RP, Vennes JA, Flink EB 1960 Diurnal variation of 17-hydroxycorticosteroids, sodium, potassium, magnesium, and creatinine in normal subjects and in cases of treated adrenal insufficiency and Cushing's syndrome. J Clin Endocrinol Metab 30:253-265
77. Krieger DT, Allen W, Rizzo F, Krieger HP 1971 Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab 32:266-284
78. Sederberg-Olsen P, Binder C, Kehlet H, Neville AM, Nielsen LM 1973 Episodic variation in plasma corticosteroids in subjects with Cushing's syndrome of differing etiology. J Clin Endocrinol Metab 36:906-910
79. Hagen C, Kehlet H, Binder C 1978 Diurnal variation in plasma cortisol and prolactin in patients with Cushing's syndrome. Acta Endocrinol (Copenh) 88:737-743
80. Boyar RM, Witkin M, Carruth A, Ramsey J 1979 Circadian cortisol secretory rhythms in Cushing's disease. J Clin Endocrinol Metab 48:760-765
81. Hellman L, Weitzman ED, Roffwarg H, Fukushima DK, Yoshida K 1970 Cortisol is secreted episodically in Cushing's syndrome. J Clin Endocrinol Metab 30:686-689
82. Glass AR, Zavadil III AP, Halberg F, Cornelissen G, Schaaf M 1984 Circadian rhythm of serum cortisol in Cushing's disease. J Clin Endocrinol Metab 59:161-165
83. Van Cauter E, Refetoff S 1985 Evidence for two subtypes of Cushing's disease based on the analysis of episodic cortisol secretion. N Engl J Med 312:1343-1349
84. Eddy RL, Jones AL, Gilliland PF, Ibarra Jr JD, Thompson JQ, MacMurry Jr JF 1973 Cushing's syndrome: a prospective study of diagnostic methods. Am J Med 55:621-630
85. Howlett TA, Drury PL, Perry L, Doniach I, Rees LH, Besser GM 1986 Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) 24:699-713
86. Laudat MH, Billaud L, Thomopoulos P, Vera O, Yllia A, Luton JP 1988 Evening urinary free corticoids: a screening test in Cushing's syndrome and incidentally discovered adrenal tumours. Acta Endocrinol (Copenh) 119:459-464
87. Besser GM, Edwards CRW 1972 Cushing's syndrome. Clin Endocrinol Metab 1:451-490
88. Butler PW, Besser GM 1968 Pituitary-adrenal function in severe depressive illness. Lancet 1:1234-1236
89. Pfohl B, Sherman B, Schlechte J, Stone R 1985 Pituitary-adrenal axis rhythm disturbances in psychiatric depression. Arch Gen Psychiatry 42:897-903
90. Ross RJ, Miell JP, Holly JM, Maheshwari H, Norman M, Abdulla AF, Buchanan CR 1991 Levels of GH binding activity, IGFBP-1, insulin, blood glucose and cortisol in intensive care patients. Clin Endocrinol (Oxf) 35:361-367
91. Papanicolaou DA, Yanovski JA, Cutler GB, Chrousos GP, Nieman LK, A single midnight cortisol measurement discriminates Cushing's syndrome from pseudo-Cushing's states. Program of the 76th Annual Meeting of The Endocrine Society, Anaheim CA, 1994 (Abstract P-1270)
92. Musselman DL, Nemeroff CB 1996 Depression and endocrine disorders: focus on the thyroid and adrenal system. Br J Psychiatry Suppl 30:123-128
93. Mosnier-Pudar H, Thomopoulos P, Bertagna X, Fournier C, Guiban D, Luton JP 1995 Long-distance and long-term follow-up of a patient with intermittent Cushing's disease by salivary cortisol measurements. Eur J Endocrinol 133:313-316
94. Lytras N, Grossman A, Perry L, Tomlin S, Wass JA, Coy DH, Schally AV, Rees LH, Besser GM 1984 Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary. Clin Endocrinol (Oxf) 20:71-84
95. Raff H, Findling JW 1989 A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clin Chem 35:596-600
96. Findling JW, Doppman JL 1994 Biochemical and radiologie diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 23:511-537
97. De Keyzer Y, Clauser E, Bertagna X 1996 The pituitary V3 vasopressin receptor and the ectopic ACTH syndrome. Curr Opin Endocrinol Diabetes 3:125-131
98. Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M 1996 Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab 81:2647-2652
99. Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, Savage MO, Afshar F, Besser GM 1993 Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) 38:73-78
100. Guilhaume B, Bertagna X, Thomsen M, Bricaire C, Vila-Porcile E, Olivier L, Racadot J, Derome P, Laudat MH, Girard F, Bricaire H, Luton JP 1988 Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies. J Clin Endocrinol Metab 66:1056-1064
101. Lamberts SW, van der Lely AJ, de Herder WW 1995 Transsphenoidal selective adenomectomy is the treatment of choice in patients with Cushing's disease. Considerations concerning preoperative medical treatment and the long-term follow-up. J Clin Endocrinol Metab 80:3111-3113
102. Bakiri F, Tarai S, Aouali R, Semrouni M, Derome P, Chitour F, Benmiloud M 1996 Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up. J Endocrinol Invest 19:572-580
103. Tyrrell JB, Wilson CB 1994 Cushing's disease. Therapy of pituitary adenomas. Endocrinol Metab Clin North Am 23:925-938
104. Dyer EH, Civil T, Visot A, Delalande O, Derome P 1994 Transsphenoidal surgery for pituitary adenomas in children. Neurosurgery 34:207-212
105. Ram Z, Nieman LK, Cutler Jr GB, Chrousos GP, Doppman JL, Old field EH 1994 Early repeat surgery for persistent Cushing's disease. J Neurosurg 80:37-45
106. Tindall GT, Herring CJ, Clark RV, Adams DA, Watts NB 1990 Cushing's disease: results of transsphenoidal microsurgery with emphasis on surgical failures. J Neurosurg 72:363-369
107. Nakane T, Kuwayama A, Watanabe M, Takahashi T, Kato T, Ichihara K, Kageyama N 1987 Long term results of transsphenoidal adenomectomy in patients with Cushing's disease. Neurosurgery 21:218-222
108. Fahlbusch R, Buchfelder M, Muller OA 1986 Transsphenoidal surgery for Cushing's disease. J R Soc Med 79:262-269
109. Howlett TA, Rees LH, Besser GM 1985 Cushing's syndrome. Clin Endocrinol Metab 14:911-945
110. Boggan JE, Tyrrell JB, Wilson CB 1983 Transsphenoidal microsurgical management of Cushing's disease. Report of 100 cases. J Neurosurg 59:195-200
111. Pass HI, Doppman JL, Nieman L, Stovroff M, Vetto J, Norton JA, Travis W, Chrousos GP, Oldfield EH, Cutler Jr GB 1990 Management of the ectopic ACTH syndrome due to thoracic carcinoids. Ann Thorac Surg 50:52-57
112. Himsworth RL, Bloomfield GA, Coombes RC, Ellison M, Gilkes JJ, Lowry PJ, Setchell KD, Slavin G, Rees LH 1977 'Big ACTH' and calcitonin in an ectopic hormone secreting tumour of the liver. Clin Endocrinol (Oxf) 7:45-62
113. Stewart PM, Gibson S, Crosby SR, Penn R, Holder R, Ferry D, Thatcher N, Phillips P, London DR, White A 1994 ACTH precursors characterize the ectopic ACTH syndrome. Clin Endocrinol (Oxf) 40:199-204
114. White A, Gibson S 1998 ACTH precusors: biological significance and clinical relevance. Clin Endocrinol (Oxf) 48:251-256
115. Fuller PJ, Lim AT, Barlow JW, White EL, Khalid BA, Copolov DL, Lolait S, Funder JW, Stockigt JR 1984 A pituitary tumor producing high molecular weight adrenocorticotropin-related peptides: clinical and cell culture studies. J Clin Endocrinol Metab 58:134-42
116. Gibson S, Ray DW, Crosby SR, Dornan TL, Jennings AM, Bevan JS, Davis JR, White A 1996 Impaired processing of proopiomelanocortin in corticotroph macroadenomas. J Clin Endocrinol Metab 81:497-502
117. Raffin-Sanson ML, Massias JF, Dumont C, Raux-Demay MC, Proeschel MF, Luton JP, Bertagna X 1996 High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab 81:4272-4277
118. Stewart PM, Walker BR, Holder G, O'Halloran D, Shackleton CH 1995 11 Beta-hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 80: 3617-3620
119. Howlett TA, Rees LH 1985 Is it possible to diagnose pituitary-dependent Cushing's disease? Ann Clin Biochem 22:550-558
120. Howlett TA, Price J, Hale AC, Doniach I, Rees LH, Wass JA, Besser G M 1985 Pituitary ACTH dependent Cushing's syndrome due to ectopic production of a bombesin-like peptide by a medullary carcinoma of the thyroid. Clin Endocrinol (Oxf) 22:91-101
121. Howlett TA, Grossman A, Rees LH, Besser GM 1986 Differential diagnosis of Cushing's syndrome. Lancet 2:871
122. Grossman AB, Howlett TA, Perry L, Coy DH, Savage MO, Lavender P, Rees LH, Besser GM 1988 CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test. Clin Endocrinol (Oxf) 29:167-178
123. Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler Jr GB 1994 A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 78:418-422
124. Flack MR, Oldfield EH, Cutler Jr GB, Zweig MH, Malley JD, Chrousos GP, Loriaux DL, Nieman LK 1992 Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Ann Intern Med 116:211-217
125. Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH 1986 An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome. Ann Intern Med 104:180-186
126. Bruno OD, Rossi MA, Contreras LN, Gomez RM, Galparsoro G, Cazado E, Kral M, Leber B, Arias D 1985 Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome. Acta Endocrinol (Copenh) 109:158-162
127. Kaye TB, Crapo L 1990 The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 112:434-444
128. Meikle AW, Lagerquist LG, Tyler FH 1975 Apparently normal pituitary-adrenal suppressibility in Cushing's syndrome: dexamethasone metabolism and plasma levels. J Lab Clin Med 86:472-478
129. Croughs RJ, Docter R, de Jong FH 1973 Comparison of oral and intravenous dexamethasone suppression tests in the differential diagnosis of Cushing's syndrome. Acta Endocrinol (Copenh) 72: 54-62
130. Biemond P, de Jong FH, Lamberts SW 1990 Continuous dexamethasone infusion for seven hours in patients with the Cushing syndrome. A superior differential diagnostic test. Ann Intern Med 112:738-742
131. Hermus AR, Pieters GF, Pesman GJ, Smals AG, Benraad TJ, Kloppenborg PW 1986 The corticotropin-releasing-hormone test vs. the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome. Lancet 2:540-544
132. Findling JW, Kehoe ME, Shaker JL, Raff H 1991 Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome. J Clin Endocrinol Metab 73:408-413
133. Aron DC, Raff H, Findling JW 1997 Effectiveness vs. efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 82: 1780-1785
134. Liddle GW, Estep HL, Kendall JWJ, Williams WCJ, Townes AW 1959 Clinical application of a new test of pituitary reserve. J Clin Endocrinol Metab 19:875-894
135. Carballeira A, Fishman LM, Jacobi JD 1976 Dual sites of inhibition by metyrapone of human adrenal steroidogenesis: correlation of in vivo and in vitro studies. J Clin Endocrinol Metab 42:687-695
136. Weiss ER, Rayyis SS, Nelson DH, Bethune JE 1969 Evaluation of stimulation and suppression tests in the etiological diagnosis of Cushing's syndrome. Ann Intern Med 71:941-949
137. Strott CA, Nugent CA, Tyler FH 1968 Cushing's syndrome caused by bronchial adenomas. Am J Med 44:97-104
138. Sindler BH, Griffing GT, Melby JC 1983 The superiority of the metyrapone test vs. the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome. Am J Med 74:657-662
139. Mason AM, Ratcliffe JG, Buckle RM, Mason AS 1972 ACTH secretion by bronchial carcinoid tumours. Clin Endocrinol (Oxf) 1:3-25
140. Jex RK, van Heerden JA, Carpenter PC, Grant CS 1985 Ectopic ACTH syndrome. Diagnostic and therapeutic aspects. Am J Surg 149:276-282
141. Blunt SB, Sandier LM, Burrin JM, Joplin GF 1990 An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings. Q J Med 77:1113-1133
142. Leinung MC, Young Jr WF, Whitaker MD, Scheithauer BW, Trastek VF, Kvols LK 1990 Diagnosis of corticotropin-producing bronchial carcinoid tumors causing Cushing's syndrome. Mayo Clin Proc 65:1314-1321
143. Avgerinos PC, Yanovski JA, Oldfield EH, Nieman LK, Cutler Jr GB 1994 The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison. Ann Intern Med 121:318-327
144. Hermus AR, Pieters GF, Pesman GJ, Smals AG, Benraad TJ, Kloppenborg PW 1986 Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease. J Clin Endocrinol Metab 62:634-639
145. Meikle AW, Jubiz W, Hutchings MP, West CD, Tyler FH 1969 A simplified metyrapone test with determination of plasma 11-deoxycortisol (metyrapone test with plasma S). J Clin Endocrinol Metab 29:985-987
146. Sparks LL, Smilo RP, Pavlatos FC, Forsham PH 1969 Experience with a rapid oral metyrapone test and the plasma ACTH content in determining the cause of Cushing's syndrome. Metabolism 18: 175-192
147. Tucci JR 1975 Metyrapone test in Cushing's disease. J Clin Endocrinol Metab 40:521-523
148. Spiger M, Jubiz W, Meikle AW, West CD, Tylor FH 1975 Single-dose metyrapone test: review of a four-year experience. Arch Intern Med 135:698-700
149. Avgerinos PC, Nieman LK, Oldfield EH, Cutler Jr GB 1996 A comparison of the overnight and the standard metyrapone test for the differential diagnosis of adrenocorticotrophin-dependent Cushing's syndrome. Clin Endocrinol (Oxf) 45:483-491
150. Vale W, Spiess J, Rivier C, Rivier J 1981 Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213:1394-1397
151. Dickstein G, DeBold CR, Gaitan D, DeCherney GS, Jackson RV, Sheldon WR J, Nicholson WE, Orth DN 1996 Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease. J Clin Endocrinol Metab 81:2934-2941
152. Nieman LK, Cutler Jr GB, Oldfield EH, Loriaux DL, Chrousos GP 1989 The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease. J Clin Endocrinol Metab 69:165-169
153. Muller OA, Stalla GK, von Werder K 1987 CRH in Cushing's syndrome. Horm Metab Res Suppl 16:51-58
154. Orth DN 1992 Corticotropin-releasing hormone in humans. Endocr Rev 13:164-191
155. Trainer PJ, Faria M, Newell-Price J, Browne P, Kopelman P, Coy DH, Besser GM, Grossman AB 1995 A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. J Clin Endocrinol Metab 80:412-417
156. Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler Jr GB 1993 A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 77:1308-1312
157. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, Avgerinos P, Paul S, Oldfield EH, Cutler Jr GB, Chrousos GP 1986 Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med 314:1329-1335
158. Nieman LK, Chrousos GP, Oldfield EH, Avgerinos PC, Cutler Jr GB Loriaux DL 1986 The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome. Ann Intern Med 105:862-867
159. Chrousos GP, Schuermeyer TH, Doppman J, Oldfield EH, Schulte HM, Gold PW, Loriaux DL 1985 NIH conference. Clinical applications of corticotropin-releasing factor. Ann Intern Med 102: 344-358
160. von Werder K, Muller OA 1985 Corticotropin- and growth hormone-releasing factor (CRF and GRF) in the diagnosis of hypothalamo-pituitary diseases. Neurosurg Rev 8:155-165
161. Orth DN, DeBold CR, DeCherney GS, Jackson RV, Alexander AN, Rivier J, Rivier C, Spiess J, Vale W 1982 Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. J Clin Endocrinol Metab 55:1017-1019
162. Fukata J, Nakai Y, Imura H, Abe K, Aono T, Demura H, Fujita T, Hibi I, Ibayashi H, Igarashi M, Irie M, Izumi K, Kageyama N, Kato K, Kumahara Y, Matsuzaki F, Matsukura S, Miyai K, Mori S, Nakagawa K, Nakajima H, Niimi M, Ogata E, Saito S, Shimizu N, Shizume K, Takahara J, Takakura K, Tomita A, Uozumi T, Wakabayashi I, Yanaihara N, Yoshimi T, Yoshinaga K 1988 Human corticotropin-releasing hormone test in normal subjects and patients with hypothalamic, pituitary or adrenocortical disorders. Endocrinol Jpn 35:491-502
163. Tanaka T, Hibi I, Shimizu N, Imura H, Tanaka K, Fukata J, Fujieda K, Ichimura T, Kuribayashi T, Ho K, Suwa S, Tachnibana K, Kato K, Ohta M, Yanaihara N 1993 Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test. Endocr J 40:581-589
164. Fukata J, Shimizu N, Imura H, Hibi I, Tanaka K, Tanaka T, Nakagawa S, Takebe K, Kimura K, Yoshinaga K, Takakura K, Demura H, Irie M, Miyachi Y, Yanaihara N, Yoshimi T, Miura K, Kuwayama A, Ota Z, Kato Y, Saito S, Takahara J, Hashimoto K, Namata H, Matsukura S 1993 Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders. Endocr J 40:597-606
165. Tanaka K, Shimizu N, Imura H, Fukata J, Hibi I, Tanaka T, Nakagawa S, Fujieda K, Takebe K, Yoshinaga K, Suwa S, Tachibana K, Kato K, Ohta M, Yanaihara N 1993 Human corticotropin-releasing hormone (hCRH) test: sex and age differences in plasma ACTH and cortisol responses and their reproducibility in healthy adults. Endocr J 40:571-579
166. Malchoff CD, Orth DN, Abboud C, Carney JA, Pairolero PC, Carey RM 1988 Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor. Am J Med 84:760-764
167. DeBold CR, Sheldon WR, DeCherney GS, Jackson RV, Alexander AN, Vale W, Rivier J, Orth DN 1984 Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J Clin Invest 73:533-538
168. Lamberts SW, Verleun T, Oosterom R, de Jong F, Hackeng WH 1984 Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab 58:298-303
169. De Keyzer Y, Auzan C, Lenne F, Beldjord C, Thibonnier M, Bertagna X, Clauser E 1994 Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett 356:215-220
170. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H 1994 Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem 269:27088-27092
171. Landon J, James VH, Stoker DJ 1965 Plasma-cortisol response to lysine-vasopressin. Comparison with other tests of human pituitary-adrenocortical function. Lancet 2:1156-1159
172. Croughs RJ 1970 Use of lysin-vasopressin in the differential diagnosis of Cushing's syndrome. Acta Endocrinol (Copenh) 65:595-607
173. Webb-Peploe MM, Spathis GS, Reed PI 1967 Cushing's syndrome: use of lysine vasopressin to distinguish overproduction of corticotrophin by pituitary from other causes of adrenal cortical hyperfunction. Lancet 1:195-197
174. Tucci JR, Espiner EA, Jagger PI, Lauler DP, Thorn GW 1968 Vasopressin in the evaluation of pituitary-adrenal function. Ann Intern Med 69:191-202
175. Bethge H, Bayer JM, Winkelmann W 1969 Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin. Acta Endocrinol (Copenh) 60:47-59
176. Coslovsky R, Wajchenberg BL, Nogueira O 1974 Hyperresponsiveness to lysine-vasopressin in Cushing's disease. Acta Endocrinol (Copenh) 75:125-132
177. Krieger DT, Luria M 1977 Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in Cushing's disease and Nelson's syndrome. J Clin Endocrinol Metab 44:361-368
178. Raux MC, Binoux M, Luton JP, Gourmelen M, Girard F 1975 Studies of ACTH secretion control in 116 cases of Cushing's syndrome. J Clin Endocrinol Metab 40:186-197
179. Catania A, Cantalamessa L, Orsatti A, Mosca G, Minonzio F, Motta P, Reschini E, Zanussi C 1984 Plasma ACTH-response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test. Metabolism 33:478-481
180. Tabarin A, San Galli F, Dezou S, Leprat F, Corcuff JB, Latapie JL, Guerin J, Roger P 1990 The corticotropin-releasing factor test in the differential diagnosis of Cushing's syndrome: a comparison with the lysine-vasopressin test. Acta Endocrinol (Copenh) 123:331-338
181. Bertagna X, Coste J, Raux-Demay MC, Letrait M, Strauch G 1994 The combined corticotropin-releasing hormone/lysine vasopressin test discloses a corticotroph phenotype. J Clin Endocrinol Metab 79:390-394
182. Favrod-Coune C, Raux-Demay MC, Proeschel MF, Bertagna X, Girard F, Luton JP 1993 Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin. Clin Endocrinol (Oxf) 38:405-410
183. Edwards CR, Kitau MJ, Chard T, Besser GM 1973 Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J 3:375-378
184. Sawyer WH, Acosta M, Manning M 1974 Structural changes in the arginine vasopressin molecule that prolong its antidiuretic action. Endocrinology 95:140-149
185. Gaillard RC, Riondel AM, Ling N, Muller AF 1988 Corticotropin releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin. Life Sci 43:1935-1344
186. Malerbi DA, Mendonca BB, Liberman B, Toledo SP, Corradini MC, Cunha-Neto MB, Fragoso MC, Wajchenberg BL 1993 The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 38:463-472
187. Newell-Price J, Perry L, Medbak S, Monson J, Savage M, Besser M, Grossman A 1997 A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 82:176-181
188. Colombo P, Passini E, Re T, Faglia G, Ambrosi B 1997 Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess. Clin Endocrinol (Oxf) 46:661-668
189. Arlt W, Dahia PL, Callies F, Nordmeyer JP, Allolio B, Grossman AB, Reincke M 1997 Ectopic ACTH production by a bronchial carcinoid tumour responsive to desmopressin in vivo and in vitro. Clin Endocrinol (Oxf) 47:623-627
190. De Keyzer Y, Lenne F, Auzan C, Jegou S, Rene P, Vaudry H, Kuhn JM, Luton JP, Clauser E, Bertagna X 1996 The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest 97:1311-1318
191. Dahia PL, Ahmed-Shuaib A, Jacobs RA, Chew SL, Honegger J, Fahlbusch R, Besser GM, Grossman AB 1996 Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors. J Clin Endocrinol Metab 81:1768-1771
192. Newell-Price J 1997 The desmopressin test and Cushing's syndrome: current state of play. Clin Endocrinol (Oxf) 47:173-174
193. Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F 1997 Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. J Clin Endocrinol Metab 82:2439-2444
194. de Keyzer Y, Lenne F, Bertagna X 1997 Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors. Eur J Endocrinol 137:715-718
195. Korbonits M, Jacobs RA, Aylwin SJ, Burrin JM, Dahia PL, Monson JP, Honegger J, Fahlbusch R, Trainer PJ, Chew SL, Besser GM, Grossman AB Expression of the hormone secretagogue receptor in pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 83:3624-3630
196. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH 1994 Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 120:817-820
197. Dwyer AJ, Frank JA, Doppman JL, Oldfield EH, Hickey AM, Cutler GB, Loriaux DL, Schiable TF 1987 Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging. Radiology 163:421-426
198. Doppman JL, Frank JA, Dwyer AJ, Oldfield EH, Miller DL, Nieman LK, Chrousos GP, Cutler Jr GB, Loriaux DL 1988 Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland. J Comput Assist Tomogr 12:728-735
199. Corrigan DF, Schaaf M, Whaley RA, Czerwinski CL, Earll JM 1977 Selective venous sampling to differentiate ectopic ACTH secretion from pituitary Cushing's syndrome. N Engl J Med 296: 861-862
200. Miller DL, Doppman JL 1991 Petrosal sinus sampling: technique and rationale. Radiology 178:37-47
201. Doppman JL, Oldfield E, Krudy AG, Chrousos GP, Schulte HM, Schaaf M, Loriaux DL 1984 Petrosal sinus sampling for Cushing syndrome: anatomical and technical considerations. Work in progress. Radiology 150:99-103
202. Findling JW, Aron DC, Tyrrell JB, Shinsako JH, Fitzgerald PA, Norman D, Wilson CB, Forsham PH 1981 Selective venous sampling for ACTH in Cushing's syndrome: differentiation between Cushing disease and the ectopic ACTH syndrome. Ann Intern Med 94:647-652
203. Drury PL, Ratter S, Tomlin S, Williams J, Dacie JE, Rees LH, Besser GM 1982 Experience with selective venous sampling in diagnosis of ACTH-dependent Cushing's syndrome. Br Med J 284: 9-12
204. Manni A, Latshaw RF, Page R, Santen RJ 1983 Simultaneous bilateral venous sampling for adrenocorticotropin in pituitary-dependent Cushing's disease: evidence for lateralization of pituitary venous drainage. J Clin Endocrinol Metab 57:1070-1073
205. Grant SJ, Stiel JN, Sorby WA, Henniker AJ 1983 Venous ACTH sampling in Cushing's syndrome. Med J Aust 1:336-337
206. Oldfield EH, Chrousos GP, Schulte HM, Schaaf M, McKeever PE, Krudy AG, Cutler Jr GB, Loriaux DL, Doppman JL 1985 Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 312:100-103
207. Cuneo R, Ross D, MacFarlane M, Espiner E, Donald RA 1985 Sequential inferior petrosal venous sampling for Cushing's disease. N Engl J Med 313:582
208. Schulte HM, Allolio B, Gunther RW, Benker G, Winkelmann W, Hollmann JP, Windeck R, Reinwein D 1987 Simultaneous bilateral catheterization of the inferior petrosal sinus in Cushing's syndrome. ACTH determination for the diagnosis and location of the side of a hypophyseal microadenoma before and after administration of corticotropin-releasing hormone. [German]. Dtsch Med Wochenschr 112:1767-1771
209. Crock PA, Pestell RG, Calenti AJ, Gilford EJ, Henderson JK, Best JD, Alford FP 1988 Multiple pituitary hormone gradients from inferior petrosal sinus sampling in Cushing's disease. Acta Endocrinol (Copenh) 119:75-80
210. McCance DR, McIlrath E, McNeill A, Gordon DS, Hadden DR, Kennedy L, Sheridan B, Atkinson AB 1989 Bilateral inferior petrosal sinus sampling as a routine procedure in ACTH-dependent Cushing's syndrome. Clin Endocrinol (Oxf) 30:157-166
211. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler Jr GB, Loriaux DL 1991 Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 325:897-905
212. Colao A, Merola B, Spaziante R, La Tessa G, Boudouresque F, Oliver C, Lombardi G 1992 Adrenocorticotropic hormone and beta-endorphin concentrations in the inferior petrosal sinuses in Cushing's disease and other pituitary diseases. J Endocrinol Invest 15:807-813
213. McNally PG, Bolia A, Absalom SR, Falconer-Smith J, Howlett TA 1993 Preliminary observations using endocrine markers of pituitary venous dilution during bilateral simultaneous inferior petrosal sinus catheterization in Cushing's syndrome: is combined CRF and TRH stimulation of value? Clin Endocrinol (Oxf) 39:681-686
214. Snow RB, Patterson Jr RH, Horwith M, Saint Louis L, Fraser RA 1988 Usefulness of preoperative inferior petrosal vein sampling in Cushing's disease. Surg Neurol 29:17-21
215. Landolt AM, Schubiger O, Maurer R, Girard J 1994 The value of inferior petrosal sinus sampling in diagnosis and treatment of Cushing's disease. Clin Endocrinol (Oxf) 40:485-492
216. de Herder WW, Uitterlinden P, Pieterman H, Tanghe HL, Kwekkeboom DJ, Pols HA, Singh R, van de Berge JH, Lamberts SW 1994 Pituitary tumour localization in patients with Cushing's disease by magnetic resonance imaging. Is there a place for petrosal sinus sampling? Clin Endocrinol (Oxf) 40:87-92
217. Lopez J, Barcelo B, Lucas T, Salame F, Alameda C, Boronat M, Salto L, Estrada J 1996 Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results. Clin Endocrinol (Oxf) 45:147-156
218. Hana V, Krsek M, Bohutova J, Marek J 1996 Determination of ACTH in the inferior petrosal sinuses in the examination of patients with hypercortisolism. [Czech]. Cas Lek Cesk 135:683-686
219. Tabarin A, Greselle JF, San-Galli F, Leprat F, Caille JM, Latapie JL, Guerin J, Roger P 1991 Usefulness of the corticotropin-releasing hormone test during bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's disease. J Clin Endocrinol Metab 73: 53-59
220. Landolt AM, Valavanis A, Girard J, Eberle AN 1986 Corticotrophin-releasing factor-test used with bilateral, simultaneous inferior petrosal sinus blood-sampling for the diagnosis of pituitary-dependent Cushing's disease. Clin Endocrinol (Oxf) 25:687-696
221. Colao A, Merola B, Tripodi FS, Di Sarno A, Esposito V, Marzullo P, La Tessa G, Spaziante R, Lombardi G 1993 Simultaneous and bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's syndrome: comparison of multihormonal assay, baseline multiple sampling and ACTH-releasing hormone test. Horm Res 40: 209-216
222. Cuneo RC, Lee W, Harper J, Mitchell K, Ward G, Atkinson RL, Salkield I, Cameron DP 1997 Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome. Clin Endocrinol (Oxf) 46:607-618
223. Boscaro M, Rampazzo A, Paoletta A, Roseano P, Pagotto U, Fallo F, Sonino N 1992 Selective venous sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome. Neuroendocrinology 55:264-268
224. Heppner C, Becker K, Saeger W, Gunther RW, Allolio B, Krone W, Winkelmann W 1997 Occult eutopic Cushing's syndrome-failure of simultaneous bilateral petrosal sinus sampling to diagnose pituitary-dependent Cushing's syndrome. Eur J Endocrinol 137: 74-78
225. Yamamoto Y, Davis DH, Nippoldt TB, Young Jr WF, Huston III J, Parisi J E 1995 False-positive inferior petrosal sinus sampling in the diagnosis of Cushing's disease. Report of two cases. J Neurosurg 83:1087-1091
226. Yanovski JA, Cutler Jr GB, Doppman JL, Miller DL, Chrousos GP, Oldfield EH, Nieman LK 1993 The limited ability of inferior petrosal sinus sampling with corticotropin-releasing hormone to distinguish Cushing's disease from pseudo-Cushing states or normal physiology. J Clin Endocrinol Metab 77:503-509
227. Seyer H, Honegger J, Schott W, Kuchle M, Huk WJ, Fahlbusch R, Frisch H 1994 Raymond's syndrome following petrosal sinus sampling. Acta Neurochir (Wien) 131:157-159
228. Sturrock ND, Jeffcoate WJ 1997 A neurological complication of inferior petrosal sinus sampling during investigation for Cushing's disease: a case report. J Neurol Neurosurg Psychiatry 62:527-528
229. Miller DL, Doppman JL, Peterman SB, Nieman LK, Oldfield EH, Chang R 1992 Neurologic complications of petrosal sinus sampling. Radiology 185:143-147
230. Schulte HM, Allolio B, Gunther RW, Benker G, Windeck R, Winkelmann W, Reinwein D 1987 Bilateral and simultaneous sinus petrosus inferior catheterization in patients with Cushing's syndrome: plasma-immunoreactive-ACTH-concentrations before and after administration of CRF. Horm Metab Res Suppl 16:66-67
231. Tabarin A, Corcuff JB, Rashedi M, Angibeau R, Caille JM, Ducassou D, Dufy B, Roger P 1992 Multihormonal response to corticotropin-releasing hormone in inferior petrosal sinus blood of one patient with Cushing's disease: comparison with in vitro secretion of the tumoral corticotropes. Acta Endocrinol (Copenh) 127:284-288
232. Zarrilli L, Colao A, Merola B, La Tessa G, Spaziante R, Tripodi FS, Di Sarno A, Marzano LA, Lombardi G 1995 Corticotropin-releasing hormone test: improvement of the diagnostic accuracy of simultaneous and bilateral inferior petrosal sinus sampling in patients with Cushing syndrome. World J Surg 19:150-153
233. Boolell M, Gilford E, Arnott R, McNeill P, Cummins J, Alford F 1990 An overview of bilateral synchronous inferior petrosal sinus sampling (BSIPSS) in the pre-operative assessment of Cushing's disease. Aust N Z J Med 20:765-770
234. Vignati F, Berselli ME, Scialfa G, Boccardi E, Loli P 1989 Bilateral and simultaneous venous sampling of inferior petrosal sinuses for ACTH and PRL determination: preoperative localization of ACTH-secreting microadenomas. J Endocrinol Invest 12:235-238
235. Mampalam TJ, Wilson CB 1988 Transsphenoidal microsurgery for Cushing's disease. A report of 216 cases. Ann Intern Med 109:487-493
236. Doppman JL, Nieman LK, Chang R, Yanovski J, Cutler Jr GB, Chrousos GP, Oldfield EH 1995 Selective venous sampling from the cavernous sinuses is not a more reliable technique than sampling from the inferior petrosal sinuses in Cushing's syndrome. J Clin Endocrinol Metab 80:2485-2489
237. Miller DL, Doppman JL, Nieman LK, Cutler Jr GB, Chrousos G, Loriaux DL, Oldfield EH 1990 Petrosal sinus sampling: discordant lateralization of ACTH-secreting pituitary microadenomas before and after stimulation with corticotropin-releasing hormone. Radiology 176:429-431
238. Doppman JL 1994 Somatostatin receptor scintigraphy and the ectopic ACTH syndrome-the solution or just another test? Am J Med 96:303-304
239. Strack TR, Schild HH, Bohl J, Beyer J, Schrezemeir J, Kahaly G 1993 Selective bilateral blood sampling from the inferior petrosal sinus in Cushing's disease: effects of corticotropin-releasing factor and thyrotropin-releasing hormone on pituitary secretion. Cardiovasc Intervent Radiol 16:287-292
240. Kalogeras KT, Nieman LK, Friedman TC, Doppman JL, Cutler Jr GB, Chrousos GP, Wilder RL, Gold PW, Yanovski JA 1996 Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion. J Clin Invest 97:2045-2050
241. Mamelak AN, Dowd CF, Tyrrell JB, McDonald JF, Wilson CB 1996 Venous angiography is needed to interpret inferior petrosal sinus and cavernous sinus sampling data for lateralizing adrenocorticotropin-secreting adenomas. J Clin Endocrinol Metab 81:475-481
242. Teramoto A, Nemoto S, Takakura K, Sasaki Y, Machida T 1993 Selective venous sampling directly from cavernous sinus in Cushing's syndrome. J Clin Endocrinol Metab 76:637-641
243. Vandorpe RA, Fox AJ, Pelz DM, Lee DH 1994 Direct sampling of the cavernous sinus in Cushing's disease. Can Assoc Radiol J 45: 234-237
244. Doppman JL, Pass HI, Nieman LK, Miller DL, Chang R, Cutler Jr GB, Chrousos GP, Jaffe GS, Norton JA 1992 Corticotropin-secreting carcinoid tumors of the thymus: diagnostic unreliability of thymic venous sampling. Radiology 184:71-74
245. Doppman JL, Pass HI, Nieman L, Cutler Jr GB, Chrousos GP, Loriaux DL 1989 Failure of bronchial lavage to detect elevated levels of adrenocorticotropin (ACTH) in patients with ACTH-producing bronchial carcinoids. J Clin Endocrinol Metab 69:1302-1304
246. Teding van Berkhout F, Croughs RJ, Kater L, Schuurman HJ, Gmelig Meyling FJ, Kooyman CD, van der Gaag RD, Jolink D, Drexhage HA 1986 Familial Cushing's syndrome due to nodular adrenocortical dysplasia. A putative receptor-antibody disease? Clin Endocrinol (Oxf) 24:299-310
247. Young Jr WF, Carney JA, Musa BU, Wulffraat NM, Lens JW, Drexhage HA 1989 Familial Cushing's syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later. N Engl J Med 321:1659-1664
248. Aiba M, Hirayama A, Iri H, Kodama T, Fujimoto Y, Kusakabe K, Akama H, Murai M, Tazaki H 1990 Primary adrenocortical micronodular dysplasia: enzyme histochemical and ultrastructural studies of two cases with a review of the literature. Hum Pathol 21:503-511
249. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL 1985 The complex of myxomas, spotty pigmentation, and endocrine over-activity. Medicine (Baltimore) 64:270-283
250. Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, Pras E, Chrousos GP 1996 Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 97:699-705
251. Marcovitz S, Wee R, Chan J, Hardy J 1987 The diagnostic accuracy of preoperative CT scanning in the evaluation of pituitary ACTH-secreting adenomas. AJR Am J Roentgenol 149:803-806
252. Buchfelder M, Nistor R, Fahlbusch R, Huk WJ 1993 The accuracy of CT and MR evaluation of the sella turcica for detection of adrenocorticotropic hormone-secreting adenomas in Cushing disease. AJNR Am J Neuroradiol 14:1183-1190
253. Newton DR, Dillon WP, Norman D, Newton TH, Wilson CB 1989 Gd-DTPA-enhanced MR imaging of pituitary adenomas. AJNR Am J Neuroradiol 10:949-954
254. Peck WW, Dillon WP, Norman D, Newton TH, Wilson CB 1989 High-resolution MR imaging of pituitary microadenomas at 1.5 T: experience with Cushing disease. AJR Am J Roentgenol 152:145-151
255. Escourolle H, Abecassis JP, Bertagna X, Guilhaume B, Pariente D, Derome P, Bonnin A, Luton JP 1993 Comparison of computerized tomography and magnetic resonance imaging for the examination of the pituitary gland in patients with Cushing's disease. Clin Endocrinol (Oxf) 39:307-313
256. Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K 1981 Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 304:156-158
257. Barrou Z, Abecassis JP, Guilhaume B, Thomopoulos P, Bertagna X, Derome P, Bonnin A, Luton JP 1997 Magnetic resonance imaging in Cushing disease. Prediction of surgical results. [French]. Presse Med 26:7-11
258. Doppman JL, Ram Z, Shawker TH, Oldfield EH 1994 Intraoperative US of the pituitary gland. Work in progress. Radiology 192: 111-115
259. Ram Z, Shawker TH, Bradford MH, Doppman JL, Oldfield EH 1995 Intraoperative ultrasound-directed resection of pituitary tumors. J Neurosurg 83:225-230
260. Fig LM, Gross MD, Shapiro B, Ehrmann DA, Freitas JE, Schteingart DE, Glazer GM, Francis IR 1988 Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome. Ann Intern Med 109:547-553
261. Doppman JL, Miller DL, Dwyer AJ, Loughlin T, Nieman L, Cutler GB, Chrousos GP, Oldfield E, Loriaux DL 1988 Macronodular adrenal hyperplasia in Cushing disease. Radiology 166:347-352
262. Doppman JL, Nieman L, Miller DL, Pass HI, Chang R, Cutler Jr GB, Schaaf M, Chrousos GP, Norton JA, Ziessman HA, Oldfield EH, Loriaux DL 1989 Ectopic adrenocorticotropic hormone syndrome: localization studies in 28 patients. Radiology 172:115-124
263. White FE, White MC, Drury PL, Fry IK, Besser GM 1982 Value of computed tomography of the abdomen and chest in investigation of Cushing's syndrome. Br Med J 284:771-774
264. Doppman JL, Pass HI, Nieman LK, Findling JW, Dwyer AJ, Feuerstein IM, Ling A, Travis WD, Cutler Jr GB, Chrousos GP, Loriaux DL 1991 Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs. CT. AJR Am J Roentgenol 156:39-43
265. Doppman JL, Nieman LK, Cutler Jr GB, Chrousos GP, Fraker DL, Norton JA, Jensen RT 1994 Adrenocorticotropic hormone-secreting islet cell tumors: are they always malignant? Radiology 190: 59-64
266. Reubi JC, Kvols LK, Waser B, Nagorney DM, Heitz PU, Charboneau JW, Reading CC, Moertel C 1990 Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 50:5969-5977
267. Phlipponneau M, Nocaudie M, Epelbaum J, De Keyzer Y, Lalau JD, Marchandise X, Bertagna X 1994 Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. J Clin Endocrinol Metab 78: 20-24
268. de Herder WW, Krenning EP, Malchoff CD, Hofland LJ, Reubi JC, Kwekkeboom DJ, Oei HY, Pols HA, Braining HA, Nobels FR, Lamberts SW 1994 Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. Am J Med 96:305-312
269. de Lange P, Koper JW, Huizenga NA, Brinkmann AO, de Jong FH, Karl M, Chrousos GP, Lamberts SW 1997 Differential hormone-dependent transcriptional activation and repression by naturally occurring human glucocorticoid receptor variants. Mol Endocrinol 11:1156-1164
270. Bronnegard M, Stierna P, Marcus C 1996 Glucocorticoid resistant syndromes-molecular basis and clinical presentations. J Neuroendocrinol 8:405-415
271. Lamberts SW 1996 The glucocorticoid insensitivity syndrome. Horm Res 45 Suppl 1:2-4
272. Arai K, Chrousos GP 1995 Syndromes of glucocorticoid and mineralocorticoid resistance. Steroids 60:173-179
273. Rupprecht R, Lesch KP, Muller U, Beck G, Beckmann H, Schulte HM 1989 Blunted adrenocorticotropin but normal beta-endorphin release after human corticotropin-releasing hormone administration in depression. J Clin Endocrinol Metab 69:600-603
274. Tsigos C, Chrousos GP 1996 Differential diagnosis and management of Cushing's syndrome. Annu Rev Med 47:443-461
275. Yanovski JA, Cutler Jr GB, Chrousos GP, Nieman LK, Prospective evaluation of the dexamethasone-suppressed corticotropin-releasing hormone test in the differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Program of the 77th Annual Meeting of The Endocrine Society, Washington DC, 1995 (Abstract OR 39-2)
276. Contreras P, Araya V 1996 Overnight dexamethasone pre-treatment improves the performance of the lysine-vasopressin test in the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 44:703-710
277. James VH, Landon J, Wynn V, Greenwood FC 1968 A fundamental defect of adrenocortical control in Cushing's disease. J Endocrinol 40:15-28
278. Trainer PJ, Besser GM 1995 The Barts Endocrine Protocols. Churchill Livingstone, London, p 4
279. Auernhammer CJ, Stalla GK, Lange M, Pfeiffer A, Muller OA 1992 Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro. J Clin Endocrinol Metab 75:552-557
280. Ambrosi B, Bochicchio D, Ferrario R, Colombo P, Faglia G 1989 Effects of the opiate agonist loperamide on pituitary-adrenal function in patients with suspected hypercortisolism. J Endocrinol Invest 12:31-35
281. Ambrosi B, Colombo P, Bochicchio D, Bassetti M, Masini B, Faglia G 1992 The silent corticotropinoma: is clinical diagnosis possible? J Endocrinol Invest 15:443-452
282. Ambrosi B, Bochicchio D, Colombo P, Fadin C, Faglia G 1993 Loperamide to diagnose Cushing's syndrome. JAMA 270:2301-2302
283. Bernini GP, Argenio GF, Cerri F, Franchi F 1994 Comparison between the suppressive effects of dexamethasone and loperamide on cortisol and ACTH secretion in some pathological conditions. J Endocrinol Invest 17:799-804
284. Jackson RV, Hockings GI, Torpy DJ, Grice JE, Crosbie GV, Walters MM, Strakosch CR 1996 New diagnostic tests for Cushing's syndrome: uses of naloxone, vasopressin and alprazolam. Clin Exp Pharmacol Physiol 23:579-581
285. Torpy DJ, Jackson RV, Grice JE, Hockings GI, Strakosch CR, Topliss D J 1993 Naloxone stimulation of ACTH secretion during petrosal sinus sampling in Cushing's syndrome. Clin Exp Pharmacol Physiol 20:299-302
286. Malerbi DA, Fragoso MC, Vieira Filho AH, Brenlha EM, Mendonca BB 1996 Cortisol and adrenocorticotropin response to desmopressin in women with Cushing's disease compared with depressive illness. J Clin Endocrinol Metab 81:2233-2237